Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Preoperative anemia and postoperative complications in patients undergoing resection of supratentorial tumors: an observational study
0
Zitationen
8
Autoren
2025
Jahr
Abstract
Introduction: The incidence of anemia in neurosurgical procedures varies depending on the population and type of surgery. In elective cranial surgery, the prevalence of moderate to severe anemia reaches up to 2.7%. Anemia has been associated with worse outcomes in terms of 30-day morbidity and mortality, as well as increased need for blood transfusions, particularly in emergency interventions. Objective: To assess the prevalence of preoperative anemia and the occurrence of postoperative complications in patients undergoing resection of supratentorial tumors. Method: Observational study analyzing patients who underwent resection of supratentorial tumors at Fundación Santa Fe de Bogotá, Colombia. Consecutive sampling was used for patients meeting inclusion criteria, and descriptive results were reported through a prevalence study. The association between preoperative anemia and the proposed outcomes was analyzed using frequency measures such as mean, median, and percentages. Results: A total of 295 patients were analyzed between 2019 and 2023, with a prevalence of preoperative anemia of 38.3% (adjusted for the city’s altitude). When analyzing anemia severity, a significant crude association was observed with renal failure and surgical site infection. Conclusion: Preoperative anemia was common in patients with supratentorial tumors and was significantly associated with acute kidney injury and surgical site infection, particularly in moderate to severe cases. Its impact on postoperative morbidity highlights the need for preoperative optimization strategies.
Ähnliche Arbeiten
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
1999 · 5.187 Zit.
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
2010 · 3.211 Zit.
Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma
2015 · 2.394 Zit.
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
1999 · 2.044 Zit.
Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
1987 · 2.019 Zit.